Cytomegalovirus disease before hematopoietic cell transplantation as a risk for complications after transplantation

Biology of Blood and Marrow Transplantation

Volumn 11, Issue 2, 2005, Pages 136-148

  Fries, Bettina C ^a   Riddell, Stanley R ^b,c   Kim, Hyung W ^b   Corey, Lawrence ^b,c   Dahlgren, Christine ^b   Woolfrey, Ann ^b,c   Boeckh, Michael ^b,c  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Cytomegalovirus; Hematopoietic cell transplantation

Indexed keywords

ACICLOVIR; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; FOSCARNET; GANCICLOVIR; IMMUNOGLOBULIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DEATH; FEMALE; GASTROINTESTINAL INFECTION; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INCIDENCE; INFANT; LUNG INFECTION; MALE; RECIPIENT; RETINITIS; RISK ASSESSMENT; SEROLOGY;

ACYCLOVIR; ADOLESCENT; ADULT; AGED; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; CYTOMEGALOVIRUS INFECTIONS; DISEASE-FREE SURVIVAL; FEMALE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; MALE; MIDDLE AGED; RISK FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 13244260712     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbmt.2004.11.016     Document Type: Article

References (35)

1. J.D. Meyers N. Flournoy E.D. Thomas Nonbacterial pneumonia after allogeneic marrow transplantation: A review of ten years' experience Rev Infect Dis 4 1982 1119-1132
2. R.A. Bowden S.J. Slichter M. Sayers et al. A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant Blood 86 1995 3598-3603
3. W.G. Nichols T.H. Price T. Gooley L. Corey M. Boeckh Transfusion-transmitted cytomegalovirus infection after receipt of leukoreduced blood products Blood 101 2003 4195-4200
4. J.M. Goodrich M. Mori C.A. Gleaves et al. Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation N Engl J Med 325 1991 1601-1607
5. H. Einsele G. Ehninger H. Hebart et al. Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation Blood 86 1995 2815-2820
6. M. Boeckh Current antiviral strategies for controlling cytomegalovirus in hematopoietic stem cell transplant recipients: Prevention and therapy Transpl Infect Dis 1 1999 165-178
7. P. Ljungman J. Aschan I. Lewensohn-Fuchs et al. Results of different strategies for reducing cytomegalovirus-associated mortality in allogeneic stem cell transplant recipients Transplantation 66 1998 1330-1334
8. A.P. Limaye R.A. Bowden D. Myerson M. Boeckh Cytomegalovirus disease occurring before engraftment in marrow transplant recipients Clin Infect Dis 24 1997 830-835
9. C. Junghanss M. Boeckh R.A. Carter et al. Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study Blood 99 2002 1978-1985
10. L.H. Calabrese M. Albrecht J. Young et al. Successful cardiac transplantation in an HIV-1-infected patient with advanced disease N Engl J Med 348 2003 2323-2328
11. J.R. Mera E. Whimbey L. Elting et al. Cytomegalovirus pneumonia in adult nontransplantation patients with cancer: Review of 20 cases occurring from 1964 through 1990 Clin Infect Dis 22 1996 1046-1050
12. S. Faderl D.A. Thomas S. O'Brien et al. Experience with alemtuzumab plus rituximab in patients with relapsed and refractory lymphoid malignancies Blood 101 2003 3413-3415
13. J.M. Goodrich R.A. Bowden L. Fisher C. Keller G. Schoch J.D. Meyers Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant Ann Intern Med 118 1993 173-178
14. P. Ljungman D. Engelhard H. Link et al. Treatment of interstitial pneumonitis due to cytomegalovirus with ganciclovir and intravenous immune globulin: Experience of European Bone Marrow Transplant Group Clin Infect Dis 14 1992 831-835
15. H. Enright R. Haake D. Weisdorf et al. Cytomegalovirus pneumonia after bone marrow transplantation. Risk factors and response to therapy Transplantation 55 1993 1339-1346
16. M. Boeckh R.A. Bowden B. Storer et al. Randomized, placebo-controlled, double-blind study of a cytomegalovirus-specific monoclonal antibody (MSL-109) for prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation Biol Blood Marrow Transplant 7 2001 343-351
17. M. Boeckh C.A. Gleaves R. Bindra J.D. Meyers Comparison of MRC-5 and U-373MG astrocytoma cells for detection of cytomegalovirus in shell vial centrifugation cultures Eur J Clin Microbiol Infect Dis 10 1991 569-572
18. J.D. Meyers E.C. Reed D.H. Shepp et al. Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation N Engl J Med 318 1988 70-75
19. M. Boeckh T.A. Gooley D. Myerson T. Cunningham G. Schoch R.A. Bowden Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: A randomized double-blind study Blood 88 1996 4063-4071
20. M. Boeckh R.A. Bowden T. Gooley D. Myerson L. Corey Successful modification of a pp65 antigenemia-based early treatment strategy for prevention of cytomegalovirus disease in allogeneic marrow transplant recipients [letter] Blood 93 1999 1781-1782
21. M. Boeckh R.A. Bowden B. Storer et al. Randomized, placebo controlled, double-blind study of a CMV glycoprotein H-specific monoclonal antibody (MSL-109) for prevention of CMV infection after allogeneic hematopoietic stem cell transplant Biol Blood Marrow Transplant 7 2001 343-351
22. E.A. Walter P.D. Greenberg M.J. Gilbert et al. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor N Engl J Med 333 1995 1038-1044
23. D. Armstrong M. Haghbin S.L. Balakrishnan M.L. Murphy Asymptomatic cytomegalovirus infection in children with leukemia Am J Dis Child 122 1971 404-407
24. Q. Nguyen E. Estey I. Raad et al. Cytomegalovirus pneumonia in adults with leukemia: An emerging problem Clin Infect Dis 32 2001 539-545
25. W.G. Nichols L. Corey T. Gooley C. Davis M. Boeckh High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: Evidence for indirect effects of primary CMV infection J Infect Dis 185 2002 273-282
26. T. Fukuda M. Boeckh K.A. Guthrie et al. Invasive aspergillosis before allogeneic hematopoietic stem cell transplantation: 10-year experience at a single transplant center Biol Blood Marrow Transplant 10 2004 494-503
27. A. Peck L. Corey M. Boeckh Pretransplantation respiratory syncytial virus infection: Impact of a strategy to delay transplantation Clin Infect Dis 39 2004 673-680
28. H. Einsele E. Roosnek N. Rufer et al. Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy Blood 99 2002 3916-3922
29. G.A. Papanicolaou J.B. Latouche C. Tan et al. Rapid expansion of cytomegalovirus-specific cytotoxic T lymphocytes by artificial antigen-presenting cells expressing a single HLA allele Blood 102 2003 2498-2505
30. A.E. Foster D.J. Gottlieb M. Marangolo et al. Rapid, large-scale generation of highly pure cytomegalovirus-specific cytotoxic T cells for adoptive immunotherapy J Hematother Stem Cell Res 12 2003 93-105
31. M. Maris M. Boeckh B. Storer et al. Immunologic recovery after hematopoietic cell transplantation with nonmyeloablative conditioning Exp Hematol 31 2003 941-952
32. A. Bacigalupo E. Tedone M.T. Van Lint et al. CMV prophylaxis with foscarnet in allogeneic bone marrow transplant recipients at high risk of developing CMV infections Bone Marrow Transplant 13 1994 783-788
33. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients Biol Blood Marrow Transplant 6 2000 659-713
34. M. Boeckh M. Huang J. Ferrenberg et al. Optimization of quantitative detection of cytomegalovirus DNA in plasma by real-time PCR J Clin Microbiol 42 2004 1142-1148
35. M. Hakki S.R. Riddell J. Storek et al. Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: Impact of host factors, drug therapy, and subclinical reactivation Blood 102 2003 3060-3067